New Alzheimer’s prevention trial in young people (Links to an external site)

Neurologist Eric McDade, DO, meets with Marty Reiswig, a participant in Alzheimer’s prevention trials at Washington University School of Medicine in St. Louis. Reiswig comes from a family with a genetic mutation that puts carriers at high risk of developing Alzheimer’s. McDade is the director of a new Alzheimer’s prevention trial involving young adults from high-risk families. The trial is evaluating whether an investigational drug can clear a key Alzheimer’s protein called amyloid beta and slow or stop the disease. (Photo: Matt Miller/School of Medicine)

Washington University School of Medicine in St. Louis is launching an international clinical trial aimed at preventing Alzheimer’s disease in people genetically destined to develop the illness at a young age. Unlike most other Alzheimer’s prevention trials, this one will enroll people before the disease has taken hold — up to 25 years before the […]

Asthma may reduce risk of brain tumors — but how? (Links to an external site)

Asthma has been associated with a lowered risk of brain tumors, and researchers at Washington University School of Medicine in St. Louis now think they know why: Immune cells activated under conditions of asthma are less able to promote the growth of brain tumors. The findings could lead to new therapeutic approaches.

There’s not much good that can be said about asthma, a breathing disease in which the airways become narrowed and inflamed. But there’s this: People with asthma seem to be less likely to develop brain tumors than others. And now, researchers at Washington University School of Medicine in St. Louis believe they have discovered why.